Crizanlizumab for Treating COVID-19 Vasculopathy
Clinical trial NCT04435184 · COMPLETED
Trial details
- NCT number
- NCT04435184
- Sponsor
- Johns Hopkins University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-09
- Primary completion
- 2020-11-28
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.